About Lowell Therapeutics
Lowell Therapeutics is a Healthcare company based in Lowell (United States) founded in 2018, and was acquired by AcelRx in November 2021. Developer of anticoagulant for the treatment of acute kidney diseases. Lowell Therapeutics has raised $1 million across 1 funding round from investors including Talphera. The company was acqui-hired. Its focus areas include Life Sciences, Nephrology, Medical Devices and Therapeutic Devices. Its competitors include Sentien Biotechnologies, Kalera Medical and 3ive Labs; 1 of its 3 listed competitors has raised funding.
Company details
Lowell Therapeutics was founded in 2018 and is based in Lowell, United States. Focus is placed on the biotechnology sector, where anticoagulants are developed specifically for acute kidney diseases. Operations center on creating targeted therapies, including the lead product Niyad, a small-molecule, short-acting anticoagulant designed for use in continuous renal replacement therapy. Geographic operations remain centered in the United States.
Funding Insights of Lowell Therapeutics
Lowell Therapeutics has successfully raised a total of $1M through 1 strategic funding round. The most recent funding activity was a Seed round of $1 million completed in November 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1M
- Total Rounds 1
- Last Round Seed — $1M
- First Round $1M
(Nov 2021)
All 1 funding rounds of Lowell Therapeutics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2021 | $1M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Lowell Therapeutics
Lowell Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Talphera.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative therapies are developed by Talphera for medically supervised settings. | acelrx.com | San Mateo, United States |
Investor details for Lowell Therapeutics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lowell Therapeutics
5 people are tracked at Lowell Therapeutics (1 in leadership, 3 in board & advisors, 1 in team).
| Name | Role | Group |
|---|---|---|
Elaine Liong | VP, Regulatory Affairs | Leadership |
Kathleen Liu | Advisor | Board & advisors |
Stuart Goldstein | Advisor | Board & advisors |
John Kellum | Advisor | Board & advisors |
Michelle Merrigan | Clinical Operations | Team |
Complete people profiles for Lowell Therapeutics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Lowell Therapeutics
3 dated milestones of Lowell Therapeutics across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Lowell Therapeutics is founded.
- Funding First funding round of $1.0M.
- Exit Acquired by AcelRx.
Competitors of Lowell Therapeutics
Lowell Therapeutics has 3 listed competitors in our database, 1 of them funded. They include Sentien Biotechnologies, Kalera Medical and 3ive Labs.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sentienbiotech.com | 2008 | Lexington, United States | $13.05M | 7 | Stem cell-based devices for acute organ failure are developed. | |
| kaleramedical.com | 2016 | San Diego, United States | Develops innovative vacuum-assisted devices for kidney stone retrieval. | |||
| 3ivelabs.com | 2018 | Roswell, United States | Develops innovative devices to restore kidney function. |
Detailed competitors of Lowell Therapeutics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nephrology
3 companies that operate in the same segment as Lowell Therapeutics (Nephrology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Hemodialysis machines with touchscreen displays are provided for medical use. | 2003 | San Jose, California, United States | USD 457.87 M | USD 119.48 M | ||
Therapeutics for kidney disease treatment are developed by Akebia Therapeutics. | 2007 | Cincinnati, Ohio, United States | USD 91 M | USD 236.2 M | 181 | |
Developer of portable hemodialysis device | 2013 | Irvine, California, United States | USD 82.5 M | 40 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Lowell Therapeutics
Complete news archive for Lowell Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lowell Therapeutics
Lowell Therapeutics was founded in 2018 and raised its 1st funding round 3 years after it was founded.
Lowell Therapeutics is headquartered in Lowell, United States. It is registered at Lowell, Massachusetts, United States.
Lowell Therapeutics is a funded company, having raised a total of $1M across 1 funding round to date. The company's 1st funding round was a Seed of $1M, raised on Nov 2021.
Lowell Therapeutics was founded in 2018 and is based in Lowell, United States. Focus is placed on the biotechnology sector, where anticoagulants are developed specifically for acute kidney diseases. Operations center on creating targeted therapies, including the lead product Niyad, a small-molecule, short-acting anticoagulant designed for use in continuous renal replacement therapy. Geographic operations remain centered in the United States.
Lowell Therapeutics's top competitors include Sentien Biotechnologies, Kalera Medical and 3ive Labs.
Lowell Therapeutics has 1 investor. Key investors include Talphera.
Yes. Lowell Therapeutics was acquired by AcelRx in November 2021.